Qutenza
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Developer of pharmaceutical drugs. The company offers Qutenza (capsaicin) 8% patch, a dermal delivery system containing prescription strength capsaicin. It is used for management of neuropathic pain associated with postherpetic neuralgia
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
- 420 Saw Mill River Road
- Ardsley, NY 10502
- United States
+1 (877) 000-0000
Qutenza Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Qutenza‘s full profile, request access.
Request full access to PitchBookQutenza Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Qutenza‘s full profile, request access.
Request full access to PitchBook